Novo Nordisk Sues Dr. Reddy’s Over Trademark Infringement for Generic Ozempic Version Olymviq
A huge legal fight just started in the medical world in March 2026. Novo Nordisk, the famous company from Denmark, is taking India’s Dr. Reddy’s Laboratories to court. The whole problem is about the name of a new drug. Dr. Reddy’s just put out a weight loss medicine called Olymviq. But Novo Nordisk says this name sounds way too much like their own star drug, Ozempic. Both of these medicines use a special chemical called semaglutide to help people lose weight. This case is happening in the Delhi High Court right now. It is a big deal for the pharma market in 2026.
Novo Nordisk thinks Olymviq will confuse regular people and doctors. They say they have spent a long time and a lot of money building the Ozempic brand globally. When a big firm like Dr. Reddy’s uses a name that sounds similar, it can lead to what lawyers call “deceptive similarity.” This basically means the names look or sound so alike that someone might buy the wrong one without even knowing it. According to news, these brand fights are becoming very common. Many companies are trying to sell cheaper versions of famous drugs. Dr. Reddy’s says their name is unique enough for people in India.pharma battle
The result of this 2026 court case will really matter for drug prices. If Dr. Reddy’s wins, it might be easier for other local shops to launch cheaper weight loss shots. If Novo Nordisk wins, they get to keep their brand name very safe and private. The judge has to look at the words and decide if they are too close. It is a tough spot for both sides.
As we go through 2026, more people want these weight loss drugs every day. Everyone wants to sell them. This lawsuit shows just how intense the competition has become. Lawyers are checking every tiny detail of the boxes and how the names sound out loud. For now, the court is still looking at the facts. We will have to wait and see who wins this 2026 .
